Use of sacubitril/valsartan in Marfan syndrome–related cardiomyopathy: The first case report

RATIONALE: Marfan syndrome is a rare cause of heart failure due to primary or secondary cardiomyopathy. Recently, sacubitril/valsartan—an angiotensin receptor blocker-neprilysin inhibitor—has been added in clinical practice as a standard therapy for heart failure. To our knowledge, there are no data...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Spoto, Silvia, Valeriani, Emanuele, Locorriere, Luciana, Anguissola, Giuseppina Beretta, Pantano, Angelo Lauria, Terracciani, Francesca, Bono, Maria Caterina, Costantino, Sebastiano, Ciccozzi, Massimo, Angeletti, Silvia
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2019
Témata:
3400
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6882602/
https://ncbi.nlm.nih.gov/pubmed/31764806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017978
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky